US Bancorp’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.7K | Sell |
16,121
-1,584
| -9% | -$5.77K | ﹤0.01% | 2698 |
|
|
2025
Q1 | $34K | Buy |
17,705
+81
| +0.5% | +$156 | ﹤0.01% | 2925 |
|
|
2024
Q4 | $33.5K | Hold |
17,624
| – | – | ﹤0.01% | 2926 |
|
|
2024
Q3 | $23.3K | Buy |
+17,624
| New | +$23.3K | ﹤0.01% | 3063 |
|
|
2021
Q3 | – | Sell |
-309
| Closed | -$1K | – | 4017 |
|
|
2021
Q2 | $1K | Hold |
309
| – | – | ﹤0.01% | 3856 |
|
|
2021
Q1 | $1K | Sell |
309
-1,691
| -85% | -$5.47K | ﹤0.01% | 3727 |
|
|
2020
Q4 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 3304 |
|
|
2020
Q3 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 3218 |
|
|
2020
Q2 | $27K | Hold |
2,000
| – | – | ﹤0.01% | 2624 |
|
|
2020
Q1 | $15K | Hold |
2,000
| – | – | ﹤0.01% | 2806 |
|
|
2019
Q4 | $13K | Hold |
2,000
| – | – | ﹤0.01% | 2983 |
|
|
2019
Q3 | $8K | Hold |
2,000
| – | – | ﹤0.01% | 3114 |
|
|
2019
Q2 | $10K | Hold |
2,000
| – | – | ﹤0.01% | 3084 |
|
|
2019
Q1 | $16K | Sell |
2,000
-8,253
| -80% | -$66K | ﹤0.01% | 2929 |
|
|
2018
Q4 | $57K | Hold |
10,253
| – | – | ﹤0.01% | 2380 |
|
|
2018
Q3 | $91K | Buy |
10,253
+4,139
| +68% | +$36.7K | ﹤0.01% | 2267 |
|
|
2018
Q2 | $61K | Hold |
6,114
| – | – | ﹤0.01% | 2470 |
|
|
2018
Q1 | $58K | Sell |
6,114
-1,486
| -20% | -$14.1K | ﹤0.01% | 2513 |
|
|
2017
Q4 | $113K | Buy |
7,600
+1,486
| +24% | +$22.1K | ﹤0.01% | 2188 |
|
|
2017
Q3 | $120K | Buy |
6,114
+5,114
| +511% | +$100K | ﹤0.01% | 2134 |
|
|
2017
Q2 | $14K | Buy |
+1,000
| New | +$14K | ﹤0.01% | 2985 |
|